Evotec (OTCMKTS:EVTCY) Stock Crosses Above Fifty Day Moving Average – Should You Sell?

Evotec SE (OTCMKTS:EVTCY)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $3.29 and traded as high as $3.78. Evotec shares last traded at $3.78, with a volume of 103,260 shares trading hands.

Evotec Trading Down 0.3%

The stock has a fifty day simple moving average of $3.29 and a 200 day simple moving average of $3.57. The firm has a market capitalization of $1.25 billion, a P/E ratio of 9.22 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.

About Evotec

Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.

The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.